Menu

©2019 easybranches.com easybranches.co.th

FDA approves new antibiotic to treat community-acquired bacterial pneumonia - FDA.gov
FDA approves new antibiotic to treat community-acquired bacterial pneumonia - FDA.gov
  • Fda.gov
  • 6 days ago

The FDA approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

FDA proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking - FDA.gov
FDA proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking - FDA.gov
  • Fda.gov
  • 10 days ago

FDA is proposing new health warnings on cigarette packages and in ads to promote greater public understanding of the negative health consequences of s...

FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization - FDA.gov
FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization - FDA.gov
  • Fda.gov
  • 17 days ago

FDA has notified four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authoriza...

FDA approves first treatment for severe hypoglycemia that can be administered without an injection - FDA.gov
FDA approves first treatment for severe hypoglycemia that can be administered without an injection - FDA.gov
  • Fda.gov
  • 1 months ago

FDA approves Baqsimi nasal powder, the first glucagon therapy for the emergency treatment of severe hypoglycemia that can be administered without an i...

FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety - FDA.gov
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety - FDA.gov
  • Fda.gov
  • 1 months ago

FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved cannabidiol products online with unsubstantiated claims.

Statement on the agency's actions to tackle the epidemic of youth vaping and court ruling on application submission deadlines for certain tobacco products, including e-cigarettes - FDA.gov
Statement on the agency's actions to tackle the epidemic of youth vaping and court ruling on application submission deadlines for certain tobacco products, including e-cigarettes - FDA.gov
  • Fda.gov
  • 1 months ago

FDA issues statement on actions to tackle youth vaping epidemic and court ruling on application deadlines for certain tobacco products, including e-ci...

FDA approves first treatment for chronic rhinosinusitis with nasal polyps - FDA.gov
FDA approves first treatment for chronic rhinosinusitis with nasal polyps - FDA.gov
  • Fda.gov
  • 2 months ago

FDA approves Dupixent to treat adults with nasal polyps accompanied by chronic rhinosinusitis or prolonged inflammation of the sinuses and nasal cavit...